Verrica Pharmaceuticals Inc Balance Sheet Statement

VRCA $14.32 0.6 4.4%

01/03/21

Adventurous, Small Cap, Style Neutral

Market Cap £266.0m

Enterprise Value £239.5m

Revenue £n/a

Quality

Value

Momentum

StockRank™

To unlock Verrica Pharmaceuticals Inc's balance sheet statement please upgrade your membership.

	2016	2017	2018	2019
Period End:	2016-12-31	2017-12-31	2018-12-31	2019-12-31
Period Length:	0	0	0	0
Currency:	USD	USD	USD	USD

Cash & Equivalents
Short Term Investments
Cash and Short Term Investments
Prepaid Expenses
Total Current Assets

Property/Plant/Equipment, Total - Gross
Accumulated Depreciation, Total
Property/Plant/Equipment, Total - Net
Other Long Term Assets, Total
Total Assets

Accounts Payable
Payable/Accrued
Accrued Expenses
Notes Payable/Short Term Debt
Total Current Liabilities

Total Long Term Debt
Total Debt
Other Liabilities, Total
Total Liabilities

Redeemable Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock - Common
Other Equity, Total
Total Equity

Total Liabilities & Shareholders’ Equity
Total Common Shares Outstanding

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.